Important Step to Bring Raman Spectroscopy to the Clinic

A Raman microspectroscope is used to capture the specific vibrational spectra of bacteria trapped on a chip.
Sven Döring / Leibniz-IPHT

European Laboratories aim to Create Common Standards

Is the tissue healthy or pathologically altered? Is the antibiotic effective against a certain bacterium or is the bacterium resistant to it? Raman spectroscopy can help to answer such questions quickly and precisely. However, one challenge for the use of the light-based analysis method in everyday clinical practice is that the results can be highly sensitive to the measurement conditions. Approaches to solving this problem are now being provided by a large-scale European cross-laboratory study led by the Leibniz Institute of Photonic Technology (Leibniz IPHT) in Jena.

A decisive step towards common standards and thus a practical application of Raman spectroscopy would be that both researchers and spectrometer manufacturers make data publicly available, recommends the research team. The study was published in the journal Analytical Chemistry.

Raman spectroscopy can be used to precisely characterize biological samples in diagnostics, microbiology, forensics or pharmacology using the unique fingerprint of the molecules. “However, the results also contain other fingerprints: those of the measurement system, for example the Raman spectrometer,” explains PD Dr. Thomas Bocklitz, head of the “Photonic Data Science” research department at Leibniz IPHT. For example, the same sample can lead to different Raman spectra if it is measured with different setups, under different conditions or at different times, says Bocklitz, who also works at Friedrich Schiller University Jena.

To raise awareness of this challenge, 86 researchers from 15 institutions in seven European countries put the comparability of Raman spectroscopic instruments with different configurations to the test. The European Union funded the “Raman4Clinics” initiative, launched by Leibniz IPHT, as a COST (European Cooperation in Science and Technology) Action. „With the largest cross-laboratory study of Raman spectroscopy experiments to date, the study is an important step toward bringing Raman spectroscopy into clinical applications“, says Prof. Jürgen Popp, scientific director of Leibniz IPHT and spokesman for the “Raman4Clinics” consortium.

The “Raman4Clinics” team concludes with a clear recommendation to both spectrometer manufacturers and the scientific community of Raman spectroscopy. “Manufacturers and scientists should calibrate the spectrometer as standard and make the corresponding software modules available open-source,” says Thomas Bocklitz. This, he says, is a viable and attractive first step to correct for the influence of measurement-related effects on Raman signals.

It is also crucial, he says, that both manufacturers and researchers make their data openly available. “We encourage scientists to actively contribute to building larger databases,” Thomas Bocklitz appeals. “This would be an enormously valuable resource for building machine learning models and chemometric methods that are tolerant of undesirable variations.”

After the research team has studied simple substances such as polystyrene and paracetamol, it is now starting to investigate complex biological samples. The results will be incorporated into the National Research Data Infrastructure (NFDI). This networked structure, funded by the German Research Foundation (DFG), is designed to systematically develop, sustainably secure and make accessible the data holdings of science and research. “Our data contribute to achieving uniform standards for Raman spectroscopy,” explains Bocklitz, who is an official contributor (“participant”) in the NFDI’s chemistry consortium (NFDI4Chem). The aim is to get internationally binding protocols for Raman spectroscopy off the ground. “We hope that our study will encourage the scientific community of Raman spectroscopy to commit to such common standards,” Thomas Bocklitz emphasizes. “Only then we can realize the full potential of this powerful non-invasive method for clinical applications.”

Wissenschaftliche Ansprechpartner:

PD Dr. Thomas Bocklitz
Leibniz Institute of Photonic Technology (Leibniz IPHT)
Head of Research Department Photonic Data Science…


Thomas Bocklitz et al., Comparability of Raman Spectroscopic Configurations: A Large Scale Cross-Laboratory Study, Anal. Chem. 2020, 92, 24, 15745–15756.

Weitere Informationen:…

Media Contact

Lavinia Meier-Ewert Presse- und Öffentlichkeitsarbeit
Leibniz-Institut für Photonische Technologien e. V.

All news from this category: Medical Engineering

The development of medical equipment, products and technical procedures is characterized by high research and development costs in a variety of fields related to the study of human medicine.

innovations-report provides informative and stimulating reports and articles on topics ranging from imaging processes, cell and tissue techniques, optical techniques, implants, orthopedic aids, clinical and medical office equipment, dialysis systems and x-ray/radiation monitoring devices to endoscopy, ultrasound, surgical techniques, and dental materials.

Back to the Homepage

Comments (0)

Write comment

Latest posts

Chemists create renewable plant-based polymers

What makes them different is that they can be easily recycled. Researchers at the Laboratory of Cluster Catalysis at St Petersburg University have synthesised polymers from biomass. What makes them…

Atom interferometry demonstrated in space for the first time

Researchers present results of experiments with atom interferometry on a sounding rocket / Further rocket missions set to follow. Extremely precise measurements are possible using atom interferometers that employ the…

Ocean bacteria release carbon into the atmosphere

Research could help scientists better estimate Earth’s carbon budget. A team led by University of Minnesota researchers has discovered that deep-sea bacteria dissolve carbon-containing rocks, releasing excess carbon into the…

Partners & Sponsors